Cliff Asness’s Contineum Therapeutics CTNM Stock Holding History
Bought
Maintained
Sold
Other funds holding CTNM
Cliff Asness's CTNM Position: Q3 2026 in Review
Cliff Asness opened a new position in Contineum Therapeutics (CTNM) in Q3 2026: 15,816 shares worth $212K. The stake represents ﹤0.01% of the portfolio and ranks #3880 among its holdings. This is a return to the name: Cliff Asness previously reported a position in CTNM as recently as Q2 2025.
Cliff Asness first reported a position in CTNM in Q2 2025 and has held it in 2 quarters since. 118 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.
- Cliff Asness held 15,816 shares of Contineum Therapeutics worth $212K as of Q3 2026.
- Contineum Therapeutics was a new Cliff Asness position in Q3 2026.
- Contineum Therapeutics made up ﹤0.01% of Cliff Asness's portfolio in Q3 2026, its #3880 holding.
- Cliff Asness first reported a position in Contineum Therapeutics in Q2 2025 and has held it in 2 quarters since.
- 118 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.
Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.